Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Banco de datos
Tipo del documento
Asunto de la revista
País de afiliación
Intervalo de año de publicación
1.
Cells ; 10(9)2021 09 02.
Artículo en Inglés | MEDLINE | ID: mdl-34571942

RESUMEN

The Corona Virus Disease 2019 (COVID-19) pandemic represents an ongoing worldwide challenge. The present large study sought to understand independent and overlapping metabolic features of samples from acutely ill patients (n = 831) that tested positive (n = 543) or negative (n = 288) for COVID-19. High-throughput metabolomics analyses were complemented with antigen and enzymatic activity assays on plasma from acutely ill patients collected while in the emergency department, at admission, or during hospitalization. Lipidomics analyses were also performed on COVID-19-positive or -negative subjects with the lowest and highest body mass index (n = 60/group). Significant changes in amino acid and fatty acid/acylcarnitine metabolism emerged as highly relevant markers of disease severity, progression, and prognosis as a function of biological and clinical variables in these patients. Further, machine learning models were trained by entering all metabolomics and clinical data from half of the COVID-19 patient cohort and then tested on the other half, yielding ~78% prediction accuracy. Finally, the extensive amount of information accumulated in this large, prospective, observational study provides a foundation for mechanistic follow-up studies and data sharing opportunities, which will advance our understanding of the characteristics of the plasma metabolism in COVID-19 and other acute critical illnesses.


Asunto(s)
COVID-19/metabolismo , Pronóstico , Enfermedad Aguda , Adulto , Aminoácidos/sangre , Índice de Masa Corporal , Carnitina/análogos & derivados , Carnitina/sangre , Estudios de Cohortes , Ácidos Grasos/sangre , Femenino , Humanos , Quinurenina/sangre , Aprendizaje Automático , Metabolómica , Persona de Mediana Edad , Estudios Prospectivos , SARS-CoV-2/aislamiento & purificación , Índice de Severidad de la Enfermedad , Triptófano/sangre
2.
Front Med (Lausanne) ; 8: 817305, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-35087853

RESUMEN

Aging and obesity independently contribute toward an endothelial dysfunction that results in an imbalanced VWF to ADAMTS13 ratio. In addition, plasma thrombin and plasmin generation are elevated and reduced, respectively, with increasing age and also with increasing body mass index (BMI). The severity risk of Corona Virus Disease 2019 (COVID-19) increases in adults older than 65 and in individuals with certain pre-existing health conditions, including obesity (>30 kg/m2). The present cross-sectional study focused on an analysis of the VWF/ADAMTS13 axis, including measurements of von Willebrand factor (VWF) antigen (VWF:AG), VWF collagen binding activity (VWF:CBA), Factor VIII antigen, ADAMTS13 antigen, and ADAMTS13 activity, in addition to thrombin and plasmin generation potential, in a demographically diverse population of COVID-19 negative (-) (n = 288) and COVID-19 positive (+) (n = 543) patient plasmas collected at the time of hospital presentation. Data were analyzed as a whole, and then after dividing patients by age (<65 and ≥65) and independently by BMI [<18.5, 18.5-24.9, 25-29.9, >30 (kg/m2)]. These analyses suggest that VWF parameters (i.e., the VWF/ADAMTS13 activity ratio) and thrombin and plasmin generation differed in COVID-19 (+), as compared to COVID-19 (-) patient plasma. Further, age (≥65) more than BMI contributed to aberrant plasma indicators of endothelial coagulopathy. Based on these findings, evaluating both the VWF/ADAMTS13 axis, along with thrombin and plasmin generation, could provide insight into the extent of endothelial dysfunction as well as the plasmatic imbalance in coagulation and fibrinolysis potential, particularly for at-risk patient populations.

3.
J Hip Preserv Surg ; 4(3): 258-259, 2017 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-28948038

RESUMEN

Prolonged sitting and mobilizing from a seated position are known to exacerbate the symptoms in patients with hip pathology. For patients who lack mobility and require extended periods of time in seated positions, such as amputees, the symptoms of femeroacetabular impingement can be debilitating and limit their ability to operate a wheelchair, use a prosthetic limb or complete activities of daily living. Hip arthroscopy surgery offers a minimally invasive technique to treat hip pathology but requires hip distraction to facilitate instrument maneuverability. Invasive methods of hip distraction have been previously described for use in amputees for hip arthroscopy. We herein describe a non-invasive surgical technique for hip distraction in the below-knee amputation patient.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA